Statistics
Publications
3
Citations
78
H-Index
3
Active since
2018
Shengwei Hong is an author at Nanjing University of Chinese Medicine specializing in pharmacology, colorectal cancer, and medicine.
Publications per year
2018–2023
3
3
ACSL4 promotes colorectal cancer and is a potential therapeutic target of emodin
Guoliang Dai, Dong Wang, Shitang Ma et al. · Phytomedicine · 2022 · 35 citations
Medicine, Oncology, Pharmacology +13
Coptisine suppresses tumor growth and progression by down-regulating MFG-E8 in colorectal cancer
Qianyu Cao, Shengwei Hong, Yuanyuan Li et al. · RSC Advances · 2018 · 33 citations · Full text
Medicine, Oncology, Pharmacology +14
Kai-yu Zhang, Yi Zhang, Shengwei Hong et al. · PLoS ONE · 2023 · 10 citations · Full text
1–3 of 3